Abiopharma

🔍 Haveli Investments, L.P. (Executive)

Company: Blend Labs, Inc. (BLND)

Report Date: 2026-06-11

Detailed Transactions and Holdings:

• Acquired 250,000 shares of Class A Common Stock at $1.7405 per share (Direct)
  Date: 2026-06-11 | Code: P | equity_swap_involved: false | shares_owned_after: 17,786,729.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Acquired 256,928 shares of Class A Common Stock at $1.6976 per share (Direct)
  Date: 2026-06-12 | Code: P | equity_swap_involved: false | shares_owned_after: 18,043,657.00 | transaction_form_type: 4 | Footnotes: F2, F4
• Acquired 650,000 shares of Class A Common Stock at $1.7232 per share (Direct)
  Date: 2026-06-15 | Code: P | equity_swap_involved: false | shares_owned_after: 18,693,657.00 | transaction_form_type: 4 | Footnotes: F3, F4
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-11 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 130,000.00 | Footnotes: F6

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.705 to $1.785, inclusive. The reporting person undertakes to provide Blend Labs, Inc. any security holder of Blend Labs, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
• F2: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.6744 to $1.73, inclusive. The reporting person undertakes to provide Blend Labs, Inc. any security holder of Blend Labs, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.705 to $1.75, inclusive. The reporting person undertakes to provide Blend Labs, Inc. any security holder of Blend Labs, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (3) to this Form 4.
• F4: Represents securities held directly by Haveli Brooks Aggregator, L.P. ("Haveli Aggregator"). Haveli Investments Software Fund I GP, LLC ("Haveli Investments Software GP"), is the general partner of Haveli Aggregator. Whanau Interests LLC ("Whanau") is the sole member of Haveli Investments Software GP. Haveli Software Management LLC ("Haveli Software Management") is the investment adviser to Haveli Investments Software GP. Haveli Investment Management LLC ("Haveli Investment Management"), a Delaware limited liability company, is the sole member of Haveli Software Management. Haveli Investments, L.P. ("Haveli Investments") is the sole member of Haveli Investment Management. Whanau is the general partner of Haveli Investments. Mr. Brian N. Sheth is managing member of Whanau.
• F5: As a result, Haveli Investments Software GP, Whanau, Haveli Software Management, Haveli Investments, Haveli Investment Management and Mr. Sheth may each be deemed to share voting and dispositive power with respect to the securities held by Haveli Aggregator. Haveli Investments Software GP, Whanau, Haveli Software Management, Haveli Investments, Haveli Investment Management and Mr. Sheth each disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
• F6: Held through a family trust of which Mr. Sheth's spouse is the trustee.